Why Exobellatech Requires Funding
Exobellatech is developing a new category of home-use exoskeletons designed to support mobility, increase personal strength, and reduce injury risk. To bring this technology to the mass market affordably, strategic funding is essential.
Where Funds Will Be Allocated
1. Engineering & Prototyping (40%)
- Mechanical design and structural testing
- Actuator and sensor selection
- Prototype iterations and physical trials
2. Electronics & Control Systems (20%)
- Embedded systems development
- Motion-tracking algorithms
- Power-management optimization
3. Safety, Compliance & Certifications (10%)
- CE / UKCA compliance
- Biomechanical safety validation
- Electrical and material safety testing
4. Manufacturing Setup (15%)
- Tooling for modular components
- Vendor selection and pre-production samples
- Reliability testing
5. Branding, Website, and Launch Assets (5%)
- Visual identity
- Product imagery
- Investor materials
6. Legal, Patents & IP (10%)
- Patent filings
- Freedom-to-operate checks
- Licensing strategy
Funding Goal
£250,000 – £400,000 (Seed Round)
This initial round takes Exobellatech from concept → working prototype → certified pre-production unit suitable for investor demos.
Investor Opportunity
By supporting Exobellatech early, investors gain access to:
- A new market category (home-assistive exoskeletons)
- Strong macro-trend alignment: aging population, labor shortages, DIY boom
- A low-cost, modular design scalable across multiple industries
- High potential for IP defensibility and future licensing
Exobellatech 